by Extivita | May 1, 1990 | Central Retinal Artery Occlusion (CRAO)
Abstract: Patients with retinal artery or vein obstruction received 150 mg of bifemelane hydrochloride daily for 1 to 11 months and other treatment (urokinase, steroid hormone, hyperbaric oxygen, or laser photocoagulation) or the latter without bifemelane. After...
